Alnylam Pharmace. buy kyron7htx
Start price
05.02.19
/
50%
€76.96
Target price
07.02.19
€108.24
Performance (%)
-5.47%
End price
07.02.19
€72.75
Summary
This prediction ended on 07.02.19 with a price of €72.75. With a performance of -5.47%, the BUY prediction for Alnylam Pharmace. by kyron7htx closed slightly in the red. kyron7htx has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alnylam Pharmace. | 7.220% | 7.220% | -47.180% | 21.437% |
| iShares Core DAX® | -1,06 % | 5,01 % | 6,60 % | 64,71 % |
| iShares Nasdaq 100 | -2,39 % | 0,86 % | 25,79 % | 88,24 % |
| iShares Nikkei 225® | -4,36 % | 1,21 % | 41,31 % | 79,31 % |
| iShares S&P 500 | -1,78 % | 1,39 % | 21,04 % | 69,60 % |
Comments by kyron7htx for this prediction
In the thread Alnylam Pharmace. diskutieren
(Stop Loss Kurs erreicht)
Stopped prediction by kyron7htx for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€69.33
08.02.19
08.02.19
€108.24
04.11.21
04.11.21
116.51%
17.07.21
17.07.21
